| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.12▲ | 1.12▲ | 1.12▲ | 1.11▲ | 1.19▼ |
| MA10 | 1.14▲ | 1.14▼ | 1.13▲ | 1.12▲ | 2.30▼ |
| MA20 | 1.14▼ | 1.13▲ | 1.14▲ | 1.20▼ | 2.86▼ |
| MA50 | 1.13▲ | 1.11▲ | 1.12▲ | 2.50▼ | 2.99▼ |
| MA100 | 1.13▲ | 1.37▼ | 1.82▼ | 3.09▼ | 2.83▼ |
| MA200 | 1.85▼ | 2.43▼ | 2.62▼ | 3.17▼ | 2.96▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.002▼ | 0.005▲ | 0.074▲ | -0.302▼ |
| RSI | 50.557▲ | 50.105▲ | 49.566▼ | 27.617▼ | 27.605▼ |
| STOCH | 14.804▼ | 25.606 | 31.150 | 43.442 | 10.739▼ |
| WILL %R | -70.000 | -63.636 | -51.852 | -54.608 | -95.659▼ |
| CCI | -17.960 | -3.557 | 40.462 | 58.339 | -109.419▼ |
|
Saturday, July 18, 2026 04:29 AM
Detailed price information for Lisata Therapeutics Inc (LSTA-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, June 16, 2026 05:59 AM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.
|
|
Wednesday, June 10, 2026 06:36 AM
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs Inc. for $4 per share in cash, plus a contingent value right worth up to an additional $3.00 per ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/08/26 | 1.11 | 1.225 | 1.08 | 1.12 | 167,482 |
| 18/08/26 | 1.10 | 1.20 | 1.10 | 1.15 | 35,070 |
| 17/08/26 | 1.09 | 1.1574 | 1.08 | 1.08 | 21,543 |
| 14/08/26 | 1.10 | 1.15 | 1.05 | 1.09 | 24,984 |
| 13/08/26 | 1.19 | 1.19 | 1.10 | 1.13 | 31,489 |
| 12/08/26 | 1.21 | 1.2794 | 1.12 | 1.18 | 37,582 |
| 11/08/26 | 1.07 | 1.25 | 1.07 | 1.21 | 120,244 |
| 10/08/26 | 1.05 | 1.11 | 1.02 | 1.09 | 104,198 |
| 07/08/26 | 1.0667 | 1.09 | 1.04 | 1.06 | 23,489 |
| 06/08/26 | 1.12 | 1.12 | 1.06 | 1.07 | 27,076 |
|
|
||||
|
|
||||
|
|